Navigation Links
For Chronic Obstructive Pulmonary Disease, Surveyed Pulmonologists Indicate That Improved Effect on Quality of Life is One of the Greatest Unmet Needs
Date:5/20/2013

BURLINGTON, Mass., May 20, 2013 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that surveyed U.S. and European pulmonologists agree that therapies offering a greater effect on quality of life is among the areas of highest unmet need. Given the high level of subjectivity and variability of tests used to measure quality of life, interviewed thought leaders state that it is difficult to differentiate therapies based on these measures. However, available clinical data and thought leader opinion indicate that the two sales-leading COPD therapies, Boehringer Ingelheim/Pfizer's Spiriva and GlaxoSmithKline's Advair/Seretide/Adoair, offer comparable efficacy on this attribute. Phase III data indicate Novartis's indacaterol/glycopyrronium may offer greater improvement in quality of life compared with these market leaders.

(Logo:  http://photos.prnewswire.com/prnh/20130103/MM36784LOGO)

The DecisionBase 2013 report entitled Chronic Obstructive Pulmonary Disease: What Gains in Efficacy Will Be Necessary to Meet Pulmonologist and Payer Expectations for Emerging LABA/LAMAs, LABA/ICSs, and MABAs? finds that surveyed U.S. pulmonologists would prescribe indacaterol/glycopyrronium to 25 percent of their COPD patients, driven by the robust Phase III efficacy data. However, Decision Resources forecasts that indacaterol/glycopyrronium will earn a more conservative patient share, constrained in part by a late launch relative to its competitors in the United States.

"Phase III data indicate that indacaterol/glycopyrronium has a strong efficacy profile," said Decision Resources Analyst Amanda Puffer . "Thought leaders are enthusiasti
'/>"/>

SOURCE Decision Resources
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Zogenix Submits New Drug Application (NDA) to U.S. Food and Drug Administration (FDA) for Zohydro™ for Treatment of Chronic Pain
2. New Chronic Wound Treatment Device Receives Award from Veterans Healthcare Program
3. Rigel Advances Asthma Programs: Two Inhaled Drug Candidates Take Aim at Acute and Chronic Lung Disease
4. New Chronic Wound Therapy Awarded at Texas Largest Life Science Event
5. Nektar Announces that FDA Grants Fast Track Designation to NKTR-181, a New Oral Opioid Analgesic Molecule, for the Treatment of Moderate to Severe Chronic Pain
6. Six-Year Follow-Up Data for SPRYCEL®? (dasatinib) 100 mg Once Daily Demonstrates 71 Percent Overall Survival in Patients with Chronic-Phase Chronic Myeloid Leukaemia Resistant or Intolerant to Imatinib
7. Hearing Loss Could Lead to Multiple Chronic Diseases for Millions of Brits
8. Remote Patient Monitoring Devices Market to 2017 - Chronic Disease Prevalence and Government Curbs on Hospital Spending to Drive the Market
9. OncoSec Featured on KTVU-TV News and in San Francisco Chronicle
10. Nektar Announces Start of Enrollment in Phase 2 Study of NKTR-181, a Novel Opioid Analgesic Molecule, for Treatment of Chronic Pain
11. CVS Caremark Charitable Trust Partners with National Association of Community Health Centers to Create Innovative Grant Program Focused on Managing Chronic Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... , FARUM, Denmark and ... On July 31, 2015 the US Food and Drug Administration ... of Major Depressive Disorder in adult patients who have failed ... current episode. TMS is a non-invasive technique for stimulating neural ... suffering from Major Depressive Disorder. The procedure has been proven ...
(Date:8/28/2015)... Massachusetts y LONDRES, 28 de agosto ... AEX: PHIA) anunció hoy su participación en el  ... exhibirá sus soluciones cardiológicas más recientes y novedosas, ... Cardiovascular, que conectan a las personas y la ... de ayudar a diagnosticar, guiar los tratamientos y ...
(Date:8/27/2015)... FRANKLIN, Mass. , Aug. 27, 2015 /PRNewswire/ ... in the KSSTA Knee Journal, compared the Arthrosurface ... "inlay" Arthroplasty design, versus an "onlay" design implant ... showed similar improvements in function and pain scores, ... showed progression of osteoarthritis (OA). However, 53% of ...
Breaking Medicine Technology:Therapy System for Treating Major Depressive Disorder Receives FDA Clearance 2Therapy System for Treating Major Depressive Disorder Receives FDA Clearance 3Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 2Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 3Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 4Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 5Study Demonstrates Dramatic Reduction in Progression of Osteoarthritis with the Arthrosurface "Inlay" Patellofemoral Implant Design Compared to Traditional "Onlay" Implant 2Study Demonstrates Dramatic Reduction in Progression of Osteoarthritis with the Arthrosurface "Inlay" Patellofemoral Implant Design Compared to Traditional "Onlay" Implant 3
... Sept. 30 /PRNewswire-Asia/ -- Winner Medical Group Inc. ... leading manufacturer of medical dressings, medical disposables and ... products industries in China, today announced that it ... store at www.purcotton.com . Opening ...
... Announces Fourth Quarter and Fiscal Year 2010 Results -- LAIYANG, China, Sept. 30 /PRNewswire-Asia-FirstCall/ -- ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... = ""; BitlyCB.alertResponse = function(data) { var s = ,; var first_result; // Results are keyed ...
Cached Medicine Technology:Winner Medical Launches Its Own PurCotton® B2C Website 2Winner Medical Launches Its Own PurCotton® B2C Website 3Jiangbo Pharmaceuticals Announces Fourth Quarter and Fiscal Year 2010 Results 2Jiangbo Pharmaceuticals Announces Fourth Quarter and Fiscal Year 2010 Results 3Jiangbo Pharmaceuticals Announces Fourth Quarter and Fiscal Year 2010 Results 4Jiangbo Pharmaceuticals Announces Fourth Quarter and Fiscal Year 2010 Results 5Jiangbo Pharmaceuticals Announces Fourth Quarter and Fiscal Year 2010 Results 6Jiangbo Pharmaceuticals Announces Fourth Quarter and Fiscal Year 2010 Results 7Jiangbo Pharmaceuticals Announces Fourth Quarter and Fiscal Year 2010 Results 8Jiangbo Pharmaceuticals Announces Fourth Quarter and Fiscal Year 2010 Results 9Jiangbo Pharmaceuticals Announces Fourth Quarter and Fiscal Year 2010 Results 10Jiangbo Pharmaceuticals Announces Fourth Quarter and Fiscal Year 2010 Results 11Jiangbo Pharmaceuticals Announces Fourth Quarter and Fiscal Year 2010 Results 12Jiangbo Pharmaceuticals Announces Fourth Quarter and Fiscal Year 2010 Results 13Jiangbo Pharmaceuticals Announces Fourth Quarter and Fiscal Year 2010 Results 14Jiangbo Pharmaceuticals Announces Fourth Quarter and Fiscal Year 2010 Results 15Jiangbo Pharmaceuticals Announces Fourth Quarter and Fiscal Year 2010 Results 16Jiangbo Pharmaceuticals Announces Fourth Quarter and Fiscal Year 2010 Results 17Jiangbo Pharmaceuticals Announces Fourth Quarter and Fiscal Year 2010 Results 18
(Date:8/30/2015)... (PRWEB) , ... August 30, 2015 , ... ... Ultrasound (HIFU) medical devices for the treatment of prostate cancer, has announced the ... this summer at the treatment center in Puerto Vallarta, Mexico. , The Sonablate® ...
(Date:8/29/2015)... ... 29, 2015 , ... "I have been a licensed physical ... specialize in manual therapy, and my invention will provide headache sufferers a solution ... muscle dysfunction throughout the body." , They developed THE RELIEVER to alleviates headaches, ...
(Date:8/29/2015)... ... August 29, 2015 , ... Next weekend is Labor ... (which astronomically, officially ends on September 22nd this year). For IT security personnel, it ... linger on which could prove far more costly than a simple headache. , Joe ...
(Date:8/29/2015)... ... August 29, 2015 , ... ... freely market and sell Arterosil and Arterosil HP, and that all claims and ... sued Vascular Health Sciences, LLC (VHS) in the United States District Court for ...
(Date:8/28/2015)... ... August 28, 2015 , ... The Kentucky State Department of ... for the position they are applying for, they are unable to pass the initial ... considering altering drug testing policies in order to be able to hire long-term, skilled ...
Breaking Medicine News(10 mins):Health News:Image Fusion Technology Combines MRI and Ultrasound Images to Treat Prostate Cancer 2Health News:Inventors and InventHelp Clients Develops Tension Reliever (LGI-1951) 2Health News:Business Cyber Security – Come Out of the Summer with a Clean Slate 2Health News:Business Cyber Security – Come Out of the Summer with a Clean Slate 3Health News:Business Cyber Security – Come Out of the Summer with a Clean Slate 4Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 2Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 3Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 4
... taking common antibacterial medication , THURSDAY, July 2 (HealthDay ... can cause sensorineural hearing loss, finds a new study. ... fibrosis patients treated over a 13-year period at Children,s ... them suffered from sensorineural hearing loss. Of those seven ...
... 2 Cardinal Health today announced that Bruce L. Downey ... completion of the planned spinoff of CareFusion Corporation, replacing John ... reasons after 22 years of service to the company as ... former chairman and chief executive officer of Barr Pharmaceuticals, Inc. ...
... ... contest for the best new industry application of its hand-centric motion capture and ... offers the most sophisticated hand-centric motion capture solutions in the marketplace. The winner ... free use for 12 months to develop their winning industry-application concept! , ...
... ,Help is Here Express, bus tour will be stopping in ... at various cities in order to help uninsured and ... medicines for free or nearly free. With the state,s unemployment ... year ago, the Partnership for Prescription Assistance (PPA) is ready ...
... , This release is available in Spanish ... of this kind of humour) favour the mental mechanisms which ... macho attitudes. Those are the conclusions of a study carried ... be released tomorrow Thursday 2nd of July in the framework ...
... SETO Holdings, Inc. (Pink Sheets: SETO) is pleased ... Virginia at 1244 Sycamore Sq. (Shopping Center), Midlothian (Richmond, VA). ... can go to ADVANCED,s web site (877allears.com) or contact Richard ... , , Forward-Looking Statements: Statements in this new ...
Cached Medicine News:Health News:Cardinal Health Appoints Bruce Downey to Board of Directors; John McCoy Retires From Board After 22 Years 2Health News:CyberGlove Systems Hosts Worldwide Contest for New Motion Capture Technology Applications 2Health News:CyberGlove Systems Hosts Worldwide Contest for New Motion Capture Technology Applications 3Health News:Partnership for Prescription Assistance Prepared to Help North Dakota Workers Hurt by Recession 2Health News:Partnership for Prescription Assistance Prepared to Help North Dakota Workers Hurt by Recession 3Health News:Partnership for Prescription Assistance Prepared to Help North Dakota Workers Hurt by Recession 4Health News:Sexist jokes favor the mental mechanisms that justify violence against women 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: